These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 30595940)
1. Development and validation of an HPLC-UV method for analysis of methylphenidate hydrochloride and loxapine succinate in an activated carbon disposal system. Bakshi P; Korey A; Fowler W; Banga AK J Pharm Anal; 2018 Dec; 8(6):349-356. PubMed ID: 30595940 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of an activated carbon-based deactivation system for the disposal of highly abused opioid medications. Gao X; Bakshi P; Sunkara Ganti S; Manian M; Korey A; Fowler W; Banga AK Drug Dev Ind Pharm; 2018 Jan; 44(1):125-134. PubMed ID: 28956648 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of an activated carbon disposal system for safe disposal of model prescription sedative medications. Dasht Bozorg B; Fowler W; Korey A; Anderson C; Banga AK Sci Rep; 2020 Feb; 10(1):2968. PubMed ID: 32076072 [TBL] [Abstract][Full Text] [Related]
4. Development and validation of a simple method for routine analysis of ractopamine hydrochloride in raw material and feed additives by HPLC. Freire EF; Borges KB; Tanimoto H; Nogueira RT; Bertolini LC; de Gaitani CM J AOAC Int; 2009; 92(3):757-64. PubMed ID: 19610364 [TBL] [Abstract][Full Text] [Related]
5. Development of Disposal Systems for Deactivation of Unused/Residual/Expired Medications. Herwadkar A; Singh N; Anderson C; Korey A; Fowler W; Banga AK Pharm Res; 2016 Jan; 33(1):110-24. PubMed ID: 26264512 [TBL] [Abstract][Full Text] [Related]
6. Activated Carbon-Based System for the Disposal of Psychoactive Medications. Song Y; Manian M; Fowler W; Korey A; Kumar Banga A Pharmaceutics; 2016 Nov; 8(4):. PubMed ID: 27827989 [TBL] [Abstract][Full Text] [Related]
7. Comparison of performance of C18 monolithic rod columns and conventional C18 particle-packed columns in liquid chromatographic determination of Estrogel and Ketoprofen gel. Nováková L; Matysová L; Solichová D; Koupparis MA; Solich P J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Dec; 813(1-2):191-7. PubMed ID: 15556533 [TBL] [Abstract][Full Text] [Related]
8. Quantitation of buclizine hydrochloride in pharmaceutical formulations and human serum by RP-HPLC. Arayne MS; Sultana N; Siddiqui FA Pak J Pharm Sci; 2006 Oct; 19(4):326-9. PubMed ID: 17105713 [TBL] [Abstract][Full Text] [Related]
9. Development and validation of a reversed-phase HPLC method for analysis of tetrahydrozoline hydrochloride in eye drop formulations. Al-Rimawi F; Zareer W; Rabie S; Quod M J Pharm Anal; 2012 Feb; 2(1):67-70. PubMed ID: 29403723 [TBL] [Abstract][Full Text] [Related]
10. Simultaneous determination of pyridoxine hydrochloride and doxylamine succinate from tablets by ion pair reversed-phase high-performance liquid chromatography (RP-HPLC). Argekar AP; Sawant JG Drug Dev Ind Pharm; 1999 Aug; 25(8):945-50. PubMed ID: 10434138 [TBL] [Abstract][Full Text] [Related]
11. Validated HPLC determination of the two fixed dose combinations (chlordiazepoxide hydrochloride and mebeverine hydrochloride; carvedilol and hydrochlorothiazide) in their tablets. Haggag RS; Shaalan RA; Belal TS J AOAC Int; 2010; 93(4):1192-200. PubMed ID: 20922951 [TBL] [Abstract][Full Text] [Related]
12. DEVELOPMENT AND VALIDATION OF THE STABILITY-INDICATING LC-UV METHOD FOR DETERMINATION OF CEFOZOPRAN HYDROCHLORIDE. Zalewski P; Garbacki P; Cielecka-Piontek J; Bednarek-Rajewska K; Krause A Acta Pol Pharm; 2015; 72(3):423-7. PubMed ID: 26642650 [TBL] [Abstract][Full Text] [Related]
13. An optimized reverse-phase high performance liquid chromatographic method for evaluating percutaneous absorption of glucosamine hydrochloride. Tekko IA; Bonner MC; Williams AC J Pharm Biomed Anal; 2006 May; 41(2):385-92. PubMed ID: 16426790 [TBL] [Abstract][Full Text] [Related]
14. Development and validation of analytical method for the estimation of lamivudine in rabbit plasma. Vikram Singh A; Nath LK; Pani NR J Pharm Anal; 2011 Nov; 1(4):251-257. PubMed ID: 29403706 [TBL] [Abstract][Full Text] [Related]
15. Development and validation of a HPLC method for the determination of buprenorphine hydrochloride, naloxone hydrochloride and noroxymorphone in a tablet formulation. Mostafavi A; Abedi G; Jamshidi A; Afzali D; Talebi M Talanta; 2009 Feb; 77(4):1415-9. PubMed ID: 19084658 [TBL] [Abstract][Full Text] [Related]
16. LC method for the analysis of cefetamet pivoxil hydrochloride in drug substance and powder for oral suspension. Morsch LM; Bittencourt CF; e Souza MJ; Milano J J Pharm Biomed Anal; 2002 Oct; 30(3):643-49. PubMed ID: 12367689 [TBL] [Abstract][Full Text] [Related]
17. Development and validation of a reversed-phase ultra-performance liquid chromatographic method for the simultaneous determination of six drugs used for combined hypertension therapy. Kaila HO; Ambasana MA; Shah AK J AOAC Int; 2013; 96(2):295-300. PubMed ID: 23767353 [TBL] [Abstract][Full Text] [Related]
18. Development and validation of HPLC method for determination of indomethacin and its two degradation products in topical gel. Nováková L; Matysová L; Havlíková L; Solich P J Pharm Biomed Anal; 2005 Apr; 37(5):899-905. PubMed ID: 15862664 [TBL] [Abstract][Full Text] [Related]
19. Concurrent high-performance liquid chromatographic measurement of loxapine and amoxapine and of their hydroxylated metabolites in plasma. Hüe B; Palomba B; Giacardy-Paty M; Bottaï T; Alric R; Petit P Ther Drug Monit; 1998 Jun; 20(3):335-9. PubMed ID: 9631933 [TBL] [Abstract][Full Text] [Related]
20. High perfomance liquid chromatography in pharmaceutical analyses. Nikolin B; Imamović B; Medanhodzić-Vuk S; Sober M Bosn J Basic Med Sci; 2004 May; 4(2):5-9. PubMed ID: 15629016 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]